Is Adding Extracorporeal Shock Wave Therapy to Physiotherapy and Corticosteroid Injection Beneficial for Frozen Shoulder
Launched by SHIN KONG WU HO-SU MEMORIAL HOSPITAL · Jul 1, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether adding a treatment called extracorporeal shock wave therapy (ESWT) to standard physiotherapy and corticosteroid injections can help people with frozen shoulder feel better and regain movement. Frozen shoulder is a painful condition that limits how much you can move your shoulder, often leading to discomfort and difficulties in daily activities. The trial aims to see if ESWT, known to promote healing and reduce pain, can improve outcomes for patients already receiving common treatments like physical therapy and steroid injections.
To participate in this trial, you should be between 20 and 80 years old, have been experiencing shoulder pain for at least a month, and have significant loss of shoulder movement. If you join, you can expect to receive the ESWT along with your regular physiotherapy and a corticosteroid injection over eight weeks. This study is actively recruiting and hopes to find out if this combination of treatments can help people with frozen shoulder recover faster and more completely.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. age between 20 to 80 years old;
- • 2. shoulder pain for ≥ 1 month;
- • 3. \> 30% loss of passive range of motion (ROM) of the affected shoulder in external rotation and/or abduction, comparing with the sound side;
- • 4. pain visual analog scale on maximal passive external rotation or abduction \> 4;
- • 5. showing willing to receive ESWT, shoulder joint injection, and attend regular physical therapy programs for 8 weeks.
- Exclusion Criteria:
- • 1. severe systemic disorders including cancer, stroke, or cardiopulmonary diseases;
- • 2. uncontrolled DM;
- • 3. rotator cuff tear or calcification of the affected shoulder;
- • 4. fracture, dislocation, or arthritis of the shoulder due to rheumatic disorders;
- • 5. a history of drug allergy to local anesthetics or corticosteroids;
- • 6. pregnancy;
- • 7. receiving ESWT, corticosteroid joint or bursa injection of the affected shoulder during the preceding three months
About Shin Kong Wu Ho Su Memorial Hospital
Shin Kong Wu Ho-Su Memorial Hospital is a leading healthcare institution dedicated to advancing medical research and patient care through innovative clinical trials. Located in Taipei, Taiwan, the hospital is committed to enhancing health outcomes by conducting rigorous, ethically sound research across various therapeutic areas. With a focus on collaboration and multidisciplinary approaches, Shin Kong Wu Ho-Su Memorial Hospital aims to contribute to the global body of medical knowledge while ensuring the highest standards of safety and efficacy for trial participants. Its state-of-the-art facilities and experienced research team enable the hospital to facilitate a wide range of clinical studies, ultimately striving to improve the quality of life for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Trial Officials
Lin-Fen Hsieh
Principal Investigator
Shin Kong Wu Ho-Su Memorial Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported